BioMarin Pharmaceutical (BMRN) Price Target Raised to $145 at RBC
Go back to BioMarin Pharmaceutical (BMRN) Price Target Raised to $145 at RBC| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.63 +0.73 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.90 | 52 Week High | $108.96 | |||
| Open | $55.80 | 52 Week Low | $62.12 | |||
| Day High | $57.00 | P/E | N/A | |||
| Day Low | $55.74 | EPS | $-1.27 | |||
| Volume | 815,104 | |||||
